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Abstract
NF-𝛋B signalling is an important factor in the development of inflammation-associated cancers. Mouse models
of Helicobacter-induced gastric cancer and colitis-associated colorectal cancer have demonstrated that classical
NF-𝛋B signalling is an important regulator of these processes. In the stomach, it has also been demonstrated that
signalling involving specific NF-𝛋B proteins, including NF-𝛋B1/p50, NF-𝛋B2/p52, and c-Rel, differentially regulate
the development of gastric pre-neoplasia. To investigate the effect of NF-𝛋B subunit loss on colitis-associated
carcinogenesis, we administered azoxymethane followed by pulsed dextran sodium sulphate to C57BL/6, Nfkb1−/−,
Nfkb2−/−, and c-Rel−/−mice. Animals lacking the c-Rel subunit were more susceptible to colitis-associated cancer
than wild-type mice, developing 3.5 times more colonic polyps per animal than wild-type mice. Nfkb2−/− mice were
resistant to colitis-associated cancer, developing fewer polyps per colon than wild-type mice (median 1 compared
to 4). To investigate the mechanisms underlying these trends, azoxymethane and dextran sodium sulphate were
administered separately to mice of each genotype. Nfkb2−/− mice developed fewer clinical signs of colitis and
exhibited less severe colitis and an attenuated cytokine response compared with all other groups following DSS
administration. Azoxymethane administration did not fully suppress colonic epithelial mitosis in c-Rel−/− mice
and less colonic epithelial apoptosis was also observed in this genotype compared to wild-type counterparts.
These observations demonstrate different functions of specific NF-𝛋B subunits in this model of colitis-associated
carcinogenesis. NF-𝛋B2/p52 is necessary for the development of colitis, whilst c-Rel-mediated signalling regulates
colonic epithelial cell turnover following DNA damage.
© 2015 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain
and Ireland.
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Introduction
Chronic idiopathic inflammatory bowel diseases, includ-
ing Crohn’s colitis and ulcerative colitis, increase an
individual’s risk of developing colorectal cancer in
proportion to the extent and duration of the under-
lying inflammatory bowel disease [1–4]. This sug-
gests that chronic colonic inflammation is pivotal to
the development of colon cancer, but the molecular
mechanisms that influence an individual’s risk of devel-
oping colitis-associated colon cancer have not been fully
established. The classical pathway of NF-κB signalling
has, however, been shown to influence both the severity
of inflammation [5] and colonic carcinogenesis in ani-
mal models [6].
The NF-κB family of proteins comprises five
members: NF-κB1 and NF-κB2, RelA (p65), RelB,
and c-Rel. These proteins bind DNA as homo- and
hetero-dimers that influence gene expression upon
interaction with the basal transcriptional machin-
ery. Engagement of tumour necrosis factor receptor
(TNFR)-1 activates the classical NF-κB pathway
leading to the translocation of NF-κB1 p50/RelA or
p50/c-Rel heterodimers into the nucleus. These induce
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the expression of genes that encode pro-inflammatory
cytokines and anti-apoptotic proteins. In contrast, lig-
ation of other TNF family receptors such as CD40 or
lymphotoxin β receptor induces both the classical and
the alternative/non-canonical NF-κB signalling path-
ways. The latter results in the processing of the NF-κB2
p100 precursor and nuclear translocation of NF-κB2
p52/RelB heterodimers, which control the expression
of chemokines and cell adhesion molecules involved
in lymphoid tissue development and B-cell maturation
[7–9].
Many studies investigating the expression and func-
tion of NF-κB subunits have highlighted the impor-
tance of classical NF-κB signalling, particularly involv-
ing RelA, in epithelial pathology. There is increas-
ing evidence that other NF-κB subunits also influ-
ence epithelial pathology. For example, c-Rel, which is
expressed in the epidermis and hair follicles of embry-
onic mice, functions in conjunction with RelA to pro-
mote basal cell proliferation and hair follicle formation
[10]. We have also recently demonstrated that RELA,
RELB, NF-κB1 p100/p50, and NF-κB2 p100/p52 are
expressed in the gastric mucosa of wild-type mice and
that specific members of the NF-κB family of proteins
differentially regulate the development of Helicobac-
ter felis-associated carcinogenesis. Mice lacking the
NF-κB1 p105/p50 subunit (Nfkb1−/−) develop gastric
atrophy of greater severity than wild-type mice follow-
ing H. felis infection, whilst mice lacking the p100/p52
subunit (Nfkb2−/−) were protected from developing gas-
tric mucosal lesions even after prolonged exposure to
H. felis [11].
Evidence from transgenic mouse models has sug-
gested that classical NF-κB signalling exerts a complex
influence over the development of colitis [5] and colon
cancer [6]. Conditional deletion of Ikkb under the con-
trol of the villin promoter is an established model of
intestinal epithelial cell-specific abrogation of classical
NF-κB signalling. When exposed to dextran sulphate
sodium (DSS), these mice exhibited an impaired heal-
ing response; however, when crossed with interleukin
10-deficient mice in standard animal house conditions,
no difference in the severity of colitis was observed
between mice with abrogated NF-κB signalling and
littermate controls [5]. Mice lacking Ikkb in intestinal
epithelial cells have also been reported to have an
increased susceptibility to developing colitis-associated
dysplasia [6]. When administered a single dose of
azoxymethane (AOM) followed by pulsed administra-
tion of DSS, more adenomata developed in the colonic
mucosa of Ikkb-deficient mice than in their wild-type
counterparts. Furthermore, these mice showed elevated
apoptotic indices following AOM/DSS administration.
This suggests that altered susceptibility to programmed
cell death influences the initiation of colonic carcino-
genesis in this model. Despite these findings, the role(s)
of specific NF-κB subunits in inflammation-associated
colon cancer development remains unknown. To address
this, we have studied the effects of DSS/AOM-induced
colitis-associated carcinogenesis in mice carrying
germline deletions of the Nfkb1, Nfkb2 or c-Rel genes
and have also investigated the impact of these deletions
on DSS-induced colitis and colonic responses to DNA
damage.
Materials and methods
Mice
Transgenic animals were maintained on a C57BL/6
genetic background. Wild-type controls were sourced
from either Charles River (Margate, UK) or the Walter
and Eliza Hall Institute (WEHI). Procedures were per-
formed with ethical approval under UK Home Office
licences or following the guidelines of the WEHI Med-
ical Research Animals Ethics Committee. Homozygote
colonies of Nfkb1−/− [12], Nfkb2−/− [13], c-Rel−/− [14],
and Tpl2−/− [15] mice were maintained in conventional
animal house conditions. Procedures were performed
on young adult (10–12 weeks) male mice at the Uni-
versity of Liverpool and on young adult female mice
at the WEHI. All control data presented are from age-
and sex-matched mice maintained in the same vivar-
ium as relevant test animals. Control mice were either
bred and maintained on-site (WEHI) or acclimatized
to local animal house conditions prior to treatment
(Liverpool).
Induction of azoxymethane and dextran sodium
sulphate (DSS)-induced adenomas
Studies were performed at both the University of Liv-
erpool and the WEHI, Melbourne. At each institution,
age- and sex-matched mice were used as controls, but
some differences in protocol were maintained due to
differences in response to DSS in local vivarium condi-
tions. At the University of Liverpool, groups of ten male
mice were administered 12.5mg/kg azoxymethane
(Sigma-Aldrich, Gillingham, UK) by i.p. injection
5 days before supplementation of drinking water with
0.5% DSS w/v (MW: 36–50 000; MP Biomedicals,
Loughborough, UK) offered ad libitum for 5 days,
followed by 16 days’ recovery. Second and third cycles
of 0.75% w/v DSS for 5 days were commenced at
days 21 and 42. Animals were culled on day 63. At
the WEHI, female mice were treated and the dose of
DSS was increased to 2% w/v. Animals were culled
at 80 days.
Induction of colitis by DSS
Drinking water was supplemented with 2% DSS for
5 days and animals were euthanized at day 6. Clin-
ical disease activity indices were recorded daily
[16]. Morphological assessment was performed by
a board-accredited veterinary pathologist (JW). Quan-
titative histology was completed using an established
inflammation scoring system [16]; all scorers were
blinded to genotype and treatment whilst scoring.
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DNA damage by azoxymethane or γ-irradiation
and crypt survival assay
Mice were administered 10mg/kg azoxymethane via
a single i.p. injection. Cell turnover was quantified
on a cell positional basis using morphological crite-
ria [17]. Whole-body γ-irradiation was administered
to mice via a closed-source 137Cs irradiator. Surviving
crypts were scored per colonic circumference; a surviv-
ing crypt was defined as containing ten or more adjacent
healthy-looking epithelial cells and a lumen [18].
Immunohistochemistry and real-time PCR (RT-PCR)
Tissue sections were immunolabelled for Ki67
(M724901; DAKO, Ely, UK), cleaved caspase 3
(AF835; R&D Systems, Abingdon, UK) or pH2AX
(#9718; Cell Signaling, Beverley, MA, USA). Ki67-
and caspase 3-positive cells within adenomas were
quantified in three high-power fields (×40 objective)
per mouse and the mean was calculated. Cell positional
scoring was performed as previously described [19]. For
RT-PCR, epithelial cell-enriched samples were prepared
using a modified Weiser technique [20]. All assays were
performed in a Roche LightCycler 480 machine. An
apoptosis-regulating gene PCR array (SABiosciences,
Crawley, UK; see Supplementary Table 1 for gene list)
was performed on pooled samples. Other qPCR assays
were performed using individual samples, primers and
probes used are identified in supplementary table 2.
Samples were normalized to Gapdh and are represented
as linearized fold changes.
Statistics
Normally distributed data were analysed by one- and
two-way ANOVAs with Dunnett’s post-hoc analysis.
Non-parametric data were assessed by Kruskal-Wallis
one-way ANOVA with Dunn’s post-hoc analysis. Cell
positional statistics were analysed by median testing
as previously described [17]. Statistical tests achieving
p< 0.05 were considered significant.
Results
Deletion of specific NF-κB subunits alters
susceptibility towards AOM/DSS-induced colonic
carcinogenesis
Groups of ten male mice were administered 12.5mg/kg
azoxymethane followed by three pulses of DSS.
Wild-type mice exhibited a modest clinical response
to this regime. Their weight increased consistently
following the first cycle of 0.5% w/v DSS [8% (± SEM
0.95)]; hence the dose was increased to 0.75% w/v DSS
for subsequent cycles. The second cycle of DSS caused
a peak weight loss of 3.6% (±2.25%); the third cycle
of DSS caused further weight loss (7.0%± 1.85%)
(Figure 1A). Nfkb1−/− mice developed a similar pat-
tern of clinical signs and area under the curve (AUC)
analysis demonstrated no significant differences in the
severity scores between wild-type mice and Nfkb1−/−
mice (Figure 1B). Nfkb2−/− mice gained weight follow-
ing each pulse of DSS (5.0%± 0.62%, 2.3%± 0.59%,
and 1.7%± 0.57%) (Figures 1A and 1B). In con-
trast, c-Rel−/− mice exhibited a greater weight loss
than wild-type mice in response to both the second
(11.3%± 6.9%, p< 0.05) and the third (19.5%± 3.3%,
p< 0.0001) cycle of DSS (Figures 1A and 1B).
Wild-type and Nfkb1−/− mice developed a median
of four colonic polyps per animal (PPA). Nfkb2−/−
mice developed fewer polyps (median 1 PPA, p< 0.01),
whilst c-Rel−/− mice showed an increased number
(median 14 PPA, p< 0.05). The polyps in c-Rel−/− mice
were larger than those seen in wild-type mice (mean
diameter 1.8mm versus 1.2mm in wild-type, p< 0.01,
Figures 1C–1E). Colonic polyps were adenomas by
histological examination (Figure 2A). Adenomas from
wild-type mice had a mean Ki67+ proliferating cell
index of 297± 20.4 cells per high power field (hpf);
adenomas examined from Nfkb1−/− and Nfkb2−/− mice
had similar proliferative indices. In contrast, adeno-
mas in c-Rel−/− mice had higher proliferation indices,
with a mean of 468± 20.5 proliferating cells per hpf
(Figures 2A, right-hand column, and 2B, p< 0.0001).
Apoptotic cells within adenomas were identified by
cleaved caspase 3 immunostaining (Figures 2A and
2C). Adenomas from wild-type mice had an apoptotic
index of 7.6± 2.6 cells per hpf, which was similar in
Nfkb1−/− and c-Rel−/− mice. However, the adenomas
that arose in Nfkb2−/− mice exhibited a lower apoptotic
index (0.6± 1.8 cells per hpf, p< 0.05).
P105/NF-κB1, the precursor of the p50/NF-κB1
transcription factor, binds to and stabilizes TPL2, a
serine/threonine MAP3 kinase responsible for ERK
activation during inflammatory responses [15]. The
absence of detectable TPL2 in Nfkb1−/− cells prompted
us to determine whether a loss of this kinase activity
contributed to the phenotype seen in the Nfkb1−/−
mice. No significant difference in visible polyps,
colon length, polyp number or diameter was observed
in AOM/DSS-treated Tpl2−/− mice (Supplementary
Figure 1). These findings indicate that neither the
direct transcriptional regulatory function of NF-κB1
nor its impact on TPL2-dependent ERK/MAPK sig-
nalling substantially influences AOM/DSS-induced
colitis-associated adenoma formation.
Collectively, these observations demonstrate that
deletion of c-Rel and Nfkb2 has inverse effects on
colonic adenoma development following DSS/AOM.
Deletion of Nfkb2 led to a reduced tumour burden,
whilst deletion of c-Rel led to substantially increased
adenoma formation.
DSS-induced inflammation is enhanced
by signalling through NF-κB2
The AOM/DSS model involves the administration
of two stimuli; we examined the effects that loss of
specific NF-κB proteins had on each of these stimuli
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Figure 1. AOM and pulsed low-dose DSS in C57BL/6, Nfkb1−/−, Nfkb2−/−, and c-Rel−/− mice. (A) Percentage change of body weight during
AOM and DSS exposure. (B) Area under the curve analysis for panel A. Data separated into first, second, and third DSS cycles. Differences
tested by two-way ANOVA and Dunnett’s post-hoc test. *p< 0.05, ****p< 0.0001 for c-Rel−/− relative to wild type (WT). (C) Gross colonic
pathology from mice of each genotype. Polypoid colonic lesions are marked with an arrowhead. (D) Number of polyps per mouse; horizontal
line at median. Differences tested by Kruskal–Wallis one-way ANOVA and Dunn’s multiple comparison tests. *p< 0.05, **p< 0.01 versus
WT. (E) Mean polyp diameter per mouse. Differences tested by one-way ANOVA and Dunnett’s post-hoc test. **p< 0.01 versus WT. Ten mice
per group.
alone. Groups of seven to ten male mice were exposed
to 2% w/v DSS for 5 days and culled on day 6. This
dose schedule has previously been shown to induce
moderately severe colitis in C57BL/6 mice in our
animal house environment. Nfkb1−/− mice developed
severe diarrhoea, rectal bleeding, and weight loss earlier
than wild-type counterparts, and showed higher disease
activity scores [16] than wild-type mice at days 2–4
(p< 0.05). Nfkb2−/− mice exhibited less severe disease
activity indices than their wild-type counterparts on
days 5 and 6 (p< 0.05) (Figure 3A). By the end of
the experimental procedure, all mice in the wild-type,
Nfkb1−/−, and c-Rel−/− groups had developed clinical
colitis with weight loss and diarrhoea; several mice also
developed haematochezia. Two of ten Nfkb2−/− mice
developed diarrhoea; none exhibited haematochezia.
AUC analysis of the clinical colitis index plot (p< 0.05)
and weight monitoring confirmed a less severe clinical
course for Nfkb2−/− mice compared with wild-type mice
(Figures 3A and 3B). Colonic mucosa from wild-type
mice treated with DSS exhibited almost complete
effacement of normal architecture, with loss of surface
and crypt epithelium; a marked, predominantly neu-
trophilic, inflammatory cell infiltrate; and submucosal
oedema (Figure 3D). Similar changes were observed in
colonic tissues from DSS-treated Nfkb1−/− and c-Rel−/−
mice. The crypts and surface epithelia of DSS-treated
Nfkb2−/− mice were more frequently intact. To quantify
these effects, a visual analogue histological inflam-
mation score was used [16]: wild-type, Nfkb1−/−, and
c-Rel−/− mice all had median inflammation scores of
6, whilst the median inflammation score for Nfkb2−/−
mice was lower at 3.5 (p< 0.005, Figure 3C).
To determine the mechanisms underlying the dif-
ferences in inflammatory response to DSS, epithelial
cell-enriched samples were prepared for RNA extrac-
tion from mice exposed to DSS. Expression of a
panel of cytokines was assayed by real-time PCR.
Wild-type mice demonstrated a 6-fold increase in
Tnfa, a> 200-fold increase in Il1b, and a> 100-fold
increase in Il6 transcript abundance following DSS
treatment (Figure 4). Txlna mRNA was not altered.
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Figure 2. Histology induced by AOM/DSS in C57BL/6, Nfkb1−/−, Nfkb2−/−, and c-Rel−/− mice. (A) H&E-, cleaved caspase 3-, and Ki67-stained
sections from mice following DSS/AOM treatment. Arrowheads highlight adenomas. (B) Mean number of Ki67-positive cells per hpf within
adenomas. (C) Mean number of cleaved caspase 3-positive cells per hpf within adenomas. Significant differences tested by one-way ANOVA
and Dunnett’s test for multiple comparisons. *p< 0.05, ****p< 0.0001 versus WT. Ten mice per group.
A similar pattern of cytokine production was observed
in mutant mice, but of differing magnitude that was
strain-dependent. Nfkb1−/− and wild-type mice had sim-
ilar levels of transcript abundance. Similarly, c-Rel−/−
mice showed an increased abundance of each cytokine
following DSS treatment, but only the differences
in the abundance of Il1b and Il6 reached statistical
significance in this genotype. Tnfa transcripts were
significantly lower in DSS-treated c-Rel−/− mice than
similarly treated wild-type mice; however, this did
not correlate with any reduction in the clinical or
histopathological severity of colitis. In Nfkb2−/− mice,
there was a generalized attenuation in cytokine response
following DSS administration. There was an increase in
Tnf, Il1b, and Il6 in response to DSS, but the differences
between untreated Nfkb2−/− mice and DSS-treated
Nfkb2−/− mice did not reach statistical significance
(Figure 4). Overall, these observations demonstrate that
signalling through NF-κB2/p52 is necessary for DSS
to induce colitis at these doses, whereas NF-κB1/p50
and c-Rel appear to have little role in the regulation of
DSS-induced colitis.
Specific NF-κB subunits differentially regulate
epithelial responses to DNA-damaging agents
To determine whether mice lacking specific NF-κB
subunits had different colonic epithelial responses to
DNA damage, 10mg/kg AOM was administered to
groups of at least six mice per genotype and colonic
tissue samples were isolated 8 or 24 h later. Cells
undergoing mitosis or apoptosis were quantified by
morphological criteria and cell positional scoring of
H&E-stained sections. This method of quantification
was validated in this setting by cell positional scoring of
sections immunostained for Ki67 and cleaved caspase
3. These alternative methods of quantification validated
the initial morphological scores, which were adopted
elsewhere (Supplementary Figure 2). AOM suppressed
colonic epithelial cell mitosis in wild-type, Nfkb1−/−,
and Nfkb2−/− mice at both time points (Figure 5A). Cell
proliferation in c-Rel−/− mice recovered more rapidly
than in wild-type mice, with similar amounts of mitosis
to the untreated state being observed 24 h after AOM
treatment (Figure 5A, p< 0.0001). Persistent mitoses
were identified in c-Rel−/− mice between cell positions
9 and 11 at 8 h (Figure 5C, shaded region) and between
cell positions 5 and 10 at 24 h after AOM administration
(Figure 5E, shaded region).
As previously described [21], administration of
AOM induced increased apoptosis in wild-type mice
(Figure 5B, 77-fold increase at 8 h, p< 0.0001). Sim-
ilar apoptosis scores were observed 8 h after AOM
treatment in mice lacking specific NF-κB subunits.
Twenty-four hours after AOM treatment, there were
signs that the apoptotic response to AOM differed
amongst the mutant animals. Nfkb2−/− mice exhibited
more colonic epithelial cell apoptosis than wild-type
mice (1.75-fold increase, p< 0.01, Figure 5B). Less
colonic epithelial apoptosis was observed in c-Rel−/−
mice than in wild-type mice at this time point (3.3-fold
less, p< 0.01, Figure 5B). Colonic epithelial cell apop-
tosis was more frequent in AOM-treated Nfkb2−/− mice
© 2015 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd J Pathol 2015; 236: 326–336
on behalf of Pathological Society of Great Britain and Ireland. www.pathsoc.org.uk www.thejournalofpathology.com
NF-κB regulates AOM/DSS-induced colonic adenomas 331
Figure 3. Impact of acute DSS administration on C57BL/6, Nfkb1−/−, Nfkb2−/−, and c-Rel−/− mice. (A) Clinical disease activity index plotted
daily during DSS administration and recovery. Differences tested by Kruskal–Wallis one-way ANOVA and Dunn’s multiple comparison test
at each time point. *p< 0.05, **p< 0.01 relative to WT. (B) Percentage change in body weight each day during DSS administration (mean
and SEM). (C) Histological inflammation score per mouse; horizontal line at median. Differences tested by one-way ANOVA and Dunnett’s
multiple comparison test. *p< 0.05, **p< 0.01, ***p< 0.001 versus WT. (D) Representative H&E-stained sections of distal colon from mice
following 2% DSS treatment (7–10 mice per group). Arrowheads highlight submucosal oedema; arrows highlight almost complete loss of
colonic epithelium.
than in wild-type mice between cell positions 4 and 9
at 8 h (Figure 5D) and between positions 1 and 5 at 24 h
(Figure 5F). This suggests that Nfkb2−/− mice have a
more robust apoptotic response to AOM administration
than wild-type mice, whilst c-Rel−/− mice undergo
less cell death than wild-type mice following the same
stimulus.
To confirm these observations, and to examine
underlying mechanisms, real-time PCR was performed
on epithelial cell-enriched samples to determine the
expression of genes involved in cell cycle progression
and apoptosis. Since the phenotypes observed in these
mice, particularly the differential apoptotic responses,
were most pronounced morphologically at 24 h, we
planned to identify underlying molecular mechanisms
at the earlier 8 h time point when precipitating cel-
lular events may be occurring. Messenger RNA was
extracted from colonic tissue samples from at least
four mice per genotype following treatment with AOM.
Transcript abundance of Ccnd1 (encoding cyclin D1)
was suppressed by DNA damage in wild-type,Nfkb1−/−,
and Nfkb2−/− mice, but not in c-Rel−/− mice follow-
ing AOM administration (Figure 5G). The abundance
of Cdk6 mRNA was unaltered in these conditions,
suggesting that either this target is not involved in
cell cycle arrest induced by AOM or its effects are
not modulated by transcriptional regulation in this
setting (Figure 5H). Apoptotic pathways affected by
AOM administration were identified by RT-PCR array.
Since at 8 h, Nfkb2−/− mice exhibited the most marked
increase in apoptotic response to AOM compared with
wild-type mice, we chose to compare these two groups.
Ten apoptosis-regulating targets demonstrated> 2-fold
changes; however, once targets with poor melt curve
characteristics, or low abundance, had been excluded,
the most significant changes were observed in Casp12
and Tnsf10. Casp12 encodes an inflammatory caspase
that has been shown to be involved in the pathogene-
sis of both experimental colitis and colitis-associated
cancer models [18], whilst Tnfs10 encodes the TNF
family ligand TRAIL, which signals through the clas-
sical NF-κB pathway. This protein has been shown to
regulate apoptosis both through a caspase-8-dependent
mechanism [22] and in inflammatory settings [23].
Real-time PCR was performed to investigate the expres-
sion of these transcripts in other genotypes. Casp12
was up-regulated in both Nfkb2−/− and Nfkb1−/− mice
following AOM treatment (Figure 5I). A 2.4-fold
increase in Tnfs10 mRNA abundance was observed in
Nfkb1−/− mice following AOM administration, but the
increased transcript abundance of Tnfs10 in Nfkb2−/−
mice compared with wild-type did not reach statistical
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Figure 4. (A–D) Relative expression of the indicated cytokines in untreated and 2% DSS-treated mice determined by real-time PCR.
Comparisons. * denotes significant difference between untreated and DSS-treated mice of the same genotype. # denotes significant
difference between DSS-treated WT and DSS-treated transgenic mice tested by two-way ANOVA and Dunnett’s multiple comparison test.
One symbol= p< 0.05; two symbols= p< 0.01; three symbols= p< 0.001; four symbols= p< 0.0001 (four mice per group).
significance (Figure 5J). Other regulators of apoptosis
under the transcriptional regulation of NF-κB pathway
signalling including xIAP, cIAP1, and cIAP2 were not
significantly altered following AOM administration.
These data suggest that c-Rel and Nfkb2/p52 regulate
responses to DNA damage in the colon. Loss of c-Rel
activity promotes cell survival following DNA damage.
In contrast, absence of Nfkb2/p52 favours cell death.
An absence of c-Rel confers protection from
γ-irradiation-induced colonic crypt destruction
Previous studies have demonstrated that when DNA
damage-induced apoptosis and suppression of mitosis
are impaired, colonic crypts may inappropriately survive
that stimulus. This effect can be modelled by the assess-
ment of crypt survival and regeneration 96 h following
sub-lethal γ-irradiation [18]. Therefore a dose of 12Gy
whole-body γ-irradiation was administered as a single
fraction to groups of six male mice of each genotype.
Animals were maintained for 96 h prior to histological
examination of the colon. Regenerating or surviving
crypts were identifiable by reported morphological cri-
teria (Figure 6A) [18]. c-Rel−/− mice had enhanced crypt
survival compared with wild-type counterparts (5.7-fold
increase, p< 0.001, Figure 6B); other transgenic groups
were not significantly different from wild-type mice. To
investigate the response to γ-irradiation further, c-Rel−/−
and wild-type mice were exposed to 1Gy whole-body
γ-irradiation and culled 4.5 h later. In these animals,
persistent mitosis was observed in the c-Rel−/− group
together with an attenuated DNA damage response,
as evidenced by a reduction in serine-139 phosphory-
lated histone H2AX between cell positions 7 and 14
(Figures 6C–6G). This is concordant with our findings
following AOM administration and offers one mecha-
nism by which c-Rel−/− mice may retain DNA-damaged
cells in the epithelium and hence become more prone to
AOM/DSS-induced colonic tumourigenesis.
Discussion
Previous studies have identified NF-κB signalling path-
ways as regulators of intestinal inflammation and car-
cinogenesis. Greten et al demonstrated that classical
NF-κB signalling influences the development of colonic
cancers in experimental colitis-associated cancer mod-
els, and that both epithelial cells and myeloid lineages
are involved in these processes [6]. The data presented
here demonstrate that different NF-κB subunits have dis-
tinct regulatory functions that influence colonic epithe-
lial responses to both DNA damage and inflammation,
and highlight the particular importance that the c-Rel
subunit plays in preventing colonic pathology.
There appears to be a hierarchy of effects associ-
ated with each of the NF-κB subunits examined in these
experiments. An absence of Nfkb1 had the least impact
on the phenotype observed in wild-type mice, with
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Figure 5. Legend on the next page
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similar numbers and sizes of tumours being observed
following AOM/DSS administration. In keeping with
this finding, the effect that a lack of NF-κB1 had on
colonic responses to either DSS colitis or DNA damage
in isolation was minimal. These observations provide
an intriguing contrast to previous studies in Nfkb1−/−
mice. Work from our laboratory demonstrated sponta-
neous gastric mucosal inflammation and a more severe
phenotype in response to chronic Helicobacter felis
infection, whilst Wang et al have previously shown that
Nfkb1−/− mice are more susceptible to radiation-induced
small intestinal apoptosis than wild-type mice [24]. This
reflects the already established evidence of a complex
relationship between NF-κB1/P50 mediated signalling
and inflammatory responses in other settings [25]. We
wanted to identify whether the known pathways that
involve NF-κB1 signalling were influencing colonic car-
cinogenesis in tandem – hence our investigation of the
Tpl2−/− mouse. However, our findings suggest that nei-
ther classical NF-κB signalling utilizing NF-κB1 nor
Tpl2-mediated activation of ERK/MAPK influences the
AOM/DSS model. The response of Nfkb1−/− mice to
inflammatory stimuli therefore remains difficult to pre-
dict, possibly reflecting pathway redundancy between
NF-κB signalling proteins, which may allow the phe-
notype induced by Nfkb1 deletion to be rescued in some
tissue contexts but not others.
Signalling mediated by c-Rel appears to
have an important role in the pathogenesis of
DSS/AOM-induced colonic tumours. Mice lacking
this subunit developed more severe colonic ade-
nomatous disease, with more abundant and larger
neoplastic lesions than wild-type mice. In our model of
DSS-induced colitis, c-Rel−/− mice developed inflam-
mation and cytokine responses similar to those of
wild-type mice, suggesting that a change in inflamma-
tory phenotype is not the predominant cause of altered
response to DSS/AOM. Intriguingly, polymorphisms in
REL, the human homologue of c-Rel, have been identi-
fied as an IBD susceptibility locus, with the minor allele
conferring an increased risk of both Crohn’s disease [26]
and ulcerative colitis [27]. Considering our observation
that the response to DSS was unaltered in c-Rel−/−
mice, the mechanism responsible for the increased IBD
susceptibility of certain REL alleles remains unclear.
DNA damage responses in c-Rel−/− mice were dif-
ferent from other groups of mice. A higher percent-
age of proliferating cells were observed in the colonic
epithelium of this mutant strain following low-dose
γ-irradiation and AOM treatment; this correlated with an
attenuatedDNAdamage response. These changes in cel-
lular response serve to enhance cell survival following
DNA damage, an event that was confirmed by the obser-
vation of greater colonic crypt survival in c-Rel−/− than
in wild-type mice following γ-irradiation. The observa-
tion that an absence of c-Rel did not inhibit epithelial cell
turnover is intriguing as it runs counter to observations
in lymphoid cells, where c-Rel appears to be critical for
mitogen-induced cell division and survival [28].
Current genome-wide association studies investi-
gating IBD cohorts have not addressed whether risk
alleles for IBD also alter an individual’s susceptibility
to colitis-associated cancer, and at present, there are no
published data on whether known polymorphisms at the
REL locus influence the risk of either colitis-associated
cancer or sporadic colorectal cancer in humans. Given
our observations and the association of REL polymor-
phisms with primary sclerosing cholangitis [29], a
colitis-associated cancer-predisposing condition, this
appears to be a pertinent question to address in the
future. In contrast to deletion of c-Rel, Nfkb2−/− mice
exhibited an attenuated response to DSS/AOM. Com-
pared with wild-type, Nfkb2−/− mice developed fewer,
smaller tumours. The response of Nfkb2−/− mice to DSS
colitis was also strikingly less severe than that of mice
of other genotypes.
Overall, these findings suggest that signalling medi-
ated by c-Rel is required to select appropriate damaged
cycling cells within the colonic mucosa to undergo
senescence or apoptosis. Loss of this function poten-
tially creates a permissive environment for the survival
of cells harbouring mutations which may become the
foci for initiation of colonic carcinogenesis. In contrast,
NF-κB2-mediated signalling appears to be critical for
the onset of DSS-induced colitis. Hence Nfkb2−/− ani-
mals subjected to DSS and AOM were protected from
developing colitis-associated colonic neoplasia pri-
marily by an attenuated inflammatory response. These
studies highlight the complex interactions between
individual NF-κB subunits in regulating colonic suscep-
tibility to inflammation and neoplasia, and in particular
Figure 5. Effect of administration of 10mg/kg AOM on cell turnover in the distal colon 8 and 24 h after administration in C57BL/6,
Nfkb1−/−, Nfkb2−/−, and c-Rel−/− mice. (A) Mean percentage of cells morphologically mitotic in untreated mice and mice 8 or 24 h
following AOM treatment. (B) Mean percentage of cells morphologically apoptotic in untreated mice and mice 8 or 24 h following AOM
treatment. Differences were tested by two-way ANOVA and Dunnett’s test for multiple comparisons. * denotes significant difference between
AOM-treated WT and AOM-treated transgenic mice at the same time point. *p< 0.05, **p< 0.01, ****p< 0.0001. † and ‡ denote significant
difference between untreated and AOM-treated mice of the same genotype. †p< 0.01, ‡p< 0.0001. All analyses performed on groups of six
mice. (C–F) Cell positional plots of mitotic cells (C, E) or apoptotic cells (D, F) 8 h (C, D) or 24 h after treatment with AOM (E, F). Shaded areas
identify cell positions where a significant difference in mitotic index was detected between WT and c-Rel−/− mice (C, E), or in apoptotic
index WT and Nfkb2−/− mice (D, F) by modified median test, p< 0.05. (G, H) Relative expression of the indicated mRNAs in colonic mucosa of
untreated mice (black bars) and mice 8 h after AOM administration (white bars). Differences tested by two-way ANOVA and Dunnett’s test
for multiple comparisons; *p< 0.005, **p< 0.001 versus untreated mice of the same genotype. ns= not significant. (I, J) Relative expression
of the indicated mRNAs in colonic mucosa 8 h after AOM administration. Significant differences in linearized expression values tested in
n= 4 mice by one-way ANOVA and Dunnett’s test for multiple comparisons. *p< 0.005, **p< 0.001 versus WT.
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Figure 6. Crypt survival following γ-irradiation in the colons of C57BL/6, Nfkb1−/−, Nfkb2−/−, and c-Rel−/− mice. (A) H&E-stained sections
of c-Rel−/−colon 96 h following 12 Gy γ-irradiation. Arrowheads highlight regenerating crypts. (B) Mean number of surviving crypts per
circumference of colon 96 h following 12 Gy γ-irradiation. Differences tested by one-way ANOVA and Dunnett’s multiple comparison test.
***p< 0.001 versus WT (six mice per group). (C–E) Mean percentages of colonocytes from C57BL/6 or c-Rel−/− mice with morphologically
mitotic (C), morphologically apoptotic (D), or expressing pH2AX (E) 4.5 h following 1 Gy γ-irradiation (two-tailed Student’s t-test *p< 0.05,
***p< 0.001). (F) Cell positional plot of pH2AX-expressing cells 4.5 h following 1 Gy γ-irradiation. Shaded area marks cell positions where
a significant difference in pH2AX staining index was detected by modified median test, p< 0.05. (G) Representative photomicrographs of
pH2AX staining in colonic mucosa following 1 Gy γ-irradiation.
highlight the critical role for signalling via c-Rel in the
regulation of colonic cell turnover.
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SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Figure S1. Impact of AOM and pulsed low-dose DSS on C57BL/6, Nfkb1−/−, and Tpl2−/− mice.
Figure S2. Quantification of Ki67- and caspase 3-stained colonic epithelial cells in untreated mice and mice treated with a single dose of 10mg
of AOM 24 h prior to necropsy.
Table S1. Genes assayed by apoptosis-regulating gene real-time PCR array.
Table S2. Primers and probes used for real-time PCR assays.
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